Self Funding of Higher-cost Medicines Needs Public Discussion
Monday, 26 May, 2014
With self funding of higher-cost medicines becoming more common in Australia, leading health authorities are calling for public discussion on the issue.
Speaking 聽at the聽eighth biennial National Medicines Symposium (NMS), Dr Jennie Louise from the University of Adelaide said there was聽聽limited formal policy debate or public discussion is occurring around the issue.
鈥淓ven when there is no funding or support available to reduce the cost of medicines, there is evidence that patients want to be told about all the treatment options, even if they can鈥檛 afford them," Dr Louise said.聽鈥淚n the future, I predict greater pressure by patient groups to fund non cost-effective medicines.
鈥淗owever, the establishment of a new market for self-funded medicines may undermine the bargaining power of government.
Dr Louise says that over time this will further increase the costs of healthcare 鈥 for example by increased consultation times and administration, monitoring treatment of side effects and other related secondary care that is required for people on high-cost treatment.
鈥淭his issue will only continue to escalate, and we need more public awareness alongside firm debate on how to address self-funded treatment,鈥 she says.
Victoria's Q3 median ED wait times the lowest on record
Victoria's quarter three performance data (January–March) has shown improvement across...
Irregularities in a clinician's cases prompt 15-month lookback
St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...
Two researchers receive $899,000 in cardiovascular funding
In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...